Cited by 339Diabetes and associated disordersDiabetes Management and ResearchAdrenal Hormones and Disorders

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype

Open access
Hawa, Mohammed I., Kolb, Hubert, Schloot, Nanette, Beyan, Huriya, Paschou, Stavroula A., Buzzetti, Raffaella, Mauricio, Didac, De Leiva, Alberto +14 more·2013·Diabetes Care

Abstract

OBJECTIVE: Specific autoantibodies characterize type 1 diabetes in childhood but are also found in adult-onset diabetes, even when initially non–insulin requiring, e.g., with latent autoimmune diabetes (LADA). We aimed to characterize adult-onset autoimmune diabetes. RESEARCH DESIGN AND METHODS: We consecutively studied 6,156 European diabetic patients attending clinics within 5 years of diagnosis (age range, 30–70 years) examined cross-sectionally clinically and for GAD antibodies (GADA) and antibodies to insulinoma-associated antigen-2 (IA-2A) and zinc-transporter 8 (ZnT8A). RESULTS: Of 6,156 patients, 541 (8.8%) had GADA and only 57 (0.9%) IA-2A or ZnT8A alone. More autoantibody-positive than autoantibody-negative patients were younger, leaner, on insulin (49.5 vs. 13.2%), and female (P < 0.0001 for each), though LADA patients (9.7% of total) did not show categorically distinct clinical features from autoantibody-negative type 2 diabetes. Similarly, more GADA patients with high (>200 World Health Organization IU) (n = 403) compared with low (n = 138) titer were female, lean, and insulin treated (54.6 vs. 39.7%) (P < 0.02 for each). Autoantibody-positive patients usually had GADA (541 of 598; 90.5%) and had LADA more often than type 1 autoimmune diabetes (odds ratio 3.3). CONCLUSIONS: Adult-onset autoimmune diabetes emerges as a prevalent form of autoimmune diabetes. Our results indicate that adult-onset autoimmune diabetes in Europe encompasses type 1 diabetes and LADA in the same broad clinical and autoantibody-positive spectrum. At diagnosis, patients with adult-onset autoimmune diabetes are usually non–insulin requiring and clinically indistinguishable from patients with type 2 diabetes, though they tend to be younger and leaner. Only with screening for autoantibodies, especially GADA, can they be identified with certainty.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc12-0931

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Latent autoimmune diabetes in adults is the most common form of autoimmune diabetes mellitus diagnosed in adults, with a prevalence in Europe, China and the United Arab Emirates between 3 and 12 times higher than that of adult-onset type 1 diabetes mellitus.

    “LADA is the most common form of autoimmune diabetes mellitus diagnosed in adults, with a prevalence in Europe, China and the United Arab Emirates between 3 and 12 times higher than that of adult-onset T1DM77–79.”

    From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [77]

    The Results section (page unavailable) reports that LADA was more prevalent than classic adult-onset autoimmune type 1 diabetes in the European cohort, with an odds ratio of 3.3. The paper does not establish the claimed comparison for China or the United Arab Emirates, or a 12-fold difference. (LLM, conf=0.89)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., Tuomilehto, J., Sarti, C., Thivolet, C., Hadden, D., Hunter, S., Schernthaner, G., Scherbaum, W. A., Williams, R., Brophy, S., Pozzilli, P., Leslie, R. D., & on behalf of the Action LADA consortium
Affiliations
  • Queen Mary University of London (GB)
  • Heinrich Heine University Düsseldorf (DE)
  • Blizard Institute, Queen Mary University of London, London, U.K.
  • Sapienza University of Rome (IT)
  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
  • Odense University Hospital, Odense, Denmark
  • Odense University Hospital (DK)
  • Finnish Institute for Health and Welfare (FI)
  • Hôpital Edouard Herriot (FR)
  • Royal Victoria Hospital (GB)
  • Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
  • Swansea University (GB)
  • Università Campus Bio-Medico (IT)
Corresponding author
Leslie, Richard David
Venue
Diabetes Care
Published
2013-03-14
Volume
36
Issue
4
Pages
908-913
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1969080742
Cited by
339
References
24
Citations by year
2026: 25 · 2025: 22 · 2024: 19 · 2023: 15 · 2022: 33 · 2021: 22 · 2020: 23 · 2019: 29 · 2018: 31 · 2017: 30 · 2016: 23 · 2015: 25 · 2014: 25 · 2013: 16 · 2012: 1
FWCI
12.87
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
Diabetes Care (publishedVersion, cc-by-nc-nd)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
latent autoimmune diabetes in adults, type 1 diabetes, glutamic acid decarboxylase antibodies, IA-2 autoantibodies, autoantibody detection, clinical phenotype, type 2 diabetes misdiagnosis, insulin requirement, antibody titers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review